ARTICLE | Company News
Roche sales and marketing update
September 17, 2001 7:00 AM UTC
ROCZ launched MabThera to treat non-Hodgkin's lymphoma (NHL) in Japan. MabThera was discovered by Idec Pharmaceuticals Corp. (IDPH, San Diego, Calif.) and is marketed in the U.S. by IDPH and partner ...